These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33769900)

  • 1. The emerging role of dupilumab in dermatological indications.
    Napolitano M; Di Guida A; Nocerino M; Fabbrocini G; Patruno C
    Expert Opin Biol Ther; 2021 Nov; 21(11):1461-1471. PubMed ID: 33769900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
    Hendricks AJ; Yosipovitch G; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab in Inflammatory Skin Diseases: A Systematic Review.
    Olbrich H; Sadik CD; Ludwig RJ; Thaçi D; Boch K
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis.
    Maloney NJ; Tegtmeyer K; Zhao J; Worswick S
    J Drugs Dermatol; 2019 Oct; 18(10):. PubMed ID: 31603635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
    van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Efficacy of Dupilumab in Alopecia Areata.
    Kulkarni M; Rohan CA; Travers JB; Serrao R
    Am J Case Rep; 2022 Jun; 23():e936488. PubMed ID: 35726185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab: A Review of Present Indications and Off-Label Uses.
    Muñoz-Bellido FJ; Moreno E; Dávila I
    J Investig Allergol Clin Immunol; 2022 Apr; 32(2):97-115. PubMed ID: 33661102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].
    Reinhold L; Lange K; Lindhof H; Homey B; Firouzi-Memarpuri P
    Dermatologie (Heidelb); 2022 Jul; 73(7):556-559. PubMed ID: 34609537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Indications of Dupilumab in Th-2 Inflammatory Disease.
    Ilaria P; Nevena S; Ersilia T; Nicoletta B; Federica T; Di Fraia M; Agniezska D; Concetta P
    Rev Recent Clin Trials; 2024; 19(1):53-61. PubMed ID: 38141197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
    Husein-ElAhmed H; Steinhoff M
    J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
    Guttman-Yassky E; Renert-Yuval Y; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Garcet S; Pavel AB; Lebwohl MG; Krueger JG
    Allergy; 2022 Mar; 77(3):897-906. PubMed ID: 34460948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
    Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
    Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients.
    Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D
    Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.
    Carnicle JM; Hendricks AJ; Shi VY
    Dermatitis; 2021 Oct; 32(1S):e80-e82. PubMed ID: 31441782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors.
    Gael M; Adam T; Mariano-Bourin M; Bursztejn AC
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1541-1551. PubMed ID: 35569006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.
    Silverberg JI; Simpson EL; Ardeleanu M; Thaçi D; Barbarot S; Bagel J; Chen Z; Eckert L; Chao J; Korotzer A; Rizova E; Rossi AB; Lu Y; Graham NMH; Hultsch T; Pirozzi G; Akinlade B
    Br J Dermatol; 2019 Jul; 181(1):80-87. PubMed ID: 30791102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
    Uchida H; Kamata M; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Acta Derm Venereol; 2019 Jun; 99(7):675-676. PubMed ID: 30938821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.